- Home
- RANI
as of 12-11-2025 3:45pm EST
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 134.6M | IPO Year: | 2021 |
| Target Price: | $8.67 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.76 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.39 - $3.87 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,200,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 414.59% | Revenue Growth (next year): | 30.15% |
AI-Powered RANI Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Rani Therapeutics Holdings Inc. (RANI)
Director, 10% Owner
Avg Cost/Share
$0.61
Shares
2,083,334
Total Value
$1,260,417.07
Owned After
2,083,334
SEC Form 4
Avg Cost/Share
$2.77
Shares
4,000,000
Total Value
$11,074,000.00
Owned After
2,379,194
SEC Form 4
Avg Cost/Share
$2.41
Shares
1,923,000
Total Value
$4,637,314.50
Owned After
2,379,194
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| IMRAN MIR A | RANI | Director, 10% Owner | Oct 23, 2025 | Buy | $0.61 | 2,083,334 | $1,260,417.07 | 2,083,334 | |
| South Cone Investments Limited Partnership | RANI | 10% Owner | Oct 21, 2025 | Sell | $2.77 | 4,000,000 | $11,074,000.00 | 2,379,194 | |
| South Cone Investments Limited Partnership | RANI | 10% Owner | Oct 20, 2025 | Sell | $2.41 | 1,923,000 | $4,637,314.50 | 2,379,194 |
Compare RANI vs Leading Stocks
See how RANI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "RANI Rani Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.